Serina Therapeutics, Inc.
SER· NYSE
Serina Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +2.01%
- Market cap
- $51.56M
- 25.4M shares
- Filings
- 517
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $130,000 | reported | |
| FY 2024 | 2024-12-31 | $56,000 | reported | |
| FY 2023 | 2023-12-31 | $3,153,000 | reported | |
| FY 2022 | 2022-12-31 | $34,000 | reported | |
| FY 2021 | 2021-12-31 | $144,000 | reported | |
| FY 2020 | 2020-12-31 | $361,000 | reported | |
| FY 2019 | 2019-12-31 | $1,728,000 | reported | |
| FY 2018 | 2018-12-31 | $1,396,000 | reported | |
| FY 2017 | 2017-12-31 | $1,404,000 | reported |
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR
